Valérie Taly

Valérie Taly is the President and CSO of METHYS Dx and a CNRS Research Director (DR1) in the MEPPOT laboratory at the Cordeliers Research Center in Paris. A pioneer of digital droplet PCR (ddPCR), she has driven major advances in detecting cancer‑specific genetic and epigenetic alterations, establishing the clinical utility of liquid biopsies and discovering new biomarkers in oncology. She has co‑authored 153 scientific publications, is co‑inventor on 18 patents. Valerie co‑founded METHYS Dx to bring these innovations into clinical practice.